News | News By Subject | News by Disease News By Date | Search News

Arrhythmia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
GlaxoSmithKline (GSK) Anti-Nausea Drug Linked to Arrhthymias     9/19/2011
HUYA Bioscience International Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile     3/3/2008
King Pharmaceuticals®, Inc. Announces the Discontinuation of Procanbid (R)     11/9/2007
Shire US Inc. (SHPGY) Announces Discontinuation of Ethmozine Tablets     8/3/2007
CV Therapeutics, Inc. (CVTX) Angina Drug Fails in New Heart Disease Test     3/7/2007
Neurion Pharmaceuticals, Inc. Renews And Expands Collaboration On HERG Ion Channel And Drug Development With Pfizer Inc. (PFE)     1/8/2004

News from Around the Web
Heart Monitor Implant Could Save Lives In Patients With Serious Immune Disease, European League Against Rheumatism Reveals     6/10/2016
3D Cardiac Tech Diagnoses Heart Fatal Arrhythmia, Johns Hopkins University Study     5/12/2016
Botox May Prevent Irregular Heartbeat After Bypass Surgery, Circulation: Arrhythmia and Electrophysiology Publishes     10/21/2015
Breathing In Diesel Exhaust Changes Your DNA, University of British Columbia Study     1/12/2015
A Novel Tool To Study Life-Threatening Arrhythmias: A Genetically Engineered Pig, NYU Langone Medical Center Study     12/16/2014
Better Athletes Have More Heart Arrhythmias, Uppsala University Hospital Study     6/13/2013
Molecular Mechanism For Some Anti-Arrhythmia Drugs Discovered By University of British Columbia Researchers     6/15/2011
Air Pollution Can Trigger Arrhythmias, Penn State University Study     3/15/2011
University of Iowa Research Points to Way to Improve Heart Treatment     3/12/2010
Coffee May Cut Risk of Heart Rhythm Problems, Kaiser Permanente Study     3/3/2010
New Genetic Link Between Cardiac Arrhythmias and Thyroid Dysfunction Identified At Weill Cornell Medical College     9/21/2009
Targeted Drug Therapy Prevents Exercise-induced Arrhythmias, Vanderbilt University School of Medicine Study     4/7/2009
New Molecular Mechanism Associated With Arrhythmias Discovered: Possible Novel Target For Treating Arrhythmias, Vanderbilt University Study     1/22/2009
Up To 2 Drinks Per Day Not Linked With Higher Risk Of Irregular Heart Beat For Women, Brigham and Women's Hospital, Harvard Medical School And University Hospital Study     12/3/2008
Popular Arthritis Drug May Disrupt Heart Rhythm, University at Buffalo Research Finds     1/28/2008

Press Releases
InCarda Initiates Enrollment Of Phase 1 Clinical Trial Of Inhaled Flecainide For The Treatment Of Cardiac Arrhythmias     8/31/2016
Texas Cardiac Arrhythmia Institute At St. David's Medical Center First In Texas To Use Micra Transcatheter Pacing System Post FDA Approval     6/22/2016
Mayne Pharma Receives FDA Approval For Dofetilide Capsules, A Generic Alternative To TIKOSYN, And Is Awarded 180 Days Market Exclusivity     6/7/2016
Armetheon Completes Acquisition Of Budiodarone And Plans Development For The Treatment Of Ventricular Tachycardia In Patients With Implantable Cardioverter Defibrillators     5/26/2016
Boston Scientific (BSX) Announces Positive Long-Term Outcomes For S-ICD System In The EFFORTLESS Study     5/9/2016
New Data Shows High-Risk Arrhythmias Detected Outside Of Traditional 48-Hour Monitoring Window With The Use Of iRhythm Technologies Inc.' ZIO Service     2/17/2016
Cardiome Pharma Corp. (COM.TO) Announces The Launch Of ESMOCARD LYO In Belgium     1/21/2016
InCarda Issued Broad Patents In U.S., Australia And Canada     10/6/2015
iRhythm Technologies Inc. Release: New Study Advances Understanding Of Asymptomatic And Episodic Arrhythmias     3/16/2015
Oregon Health & Science University (OHSU) Release: Research Uncovers Potential Therapy To Prevent Arrhythmias, Sudden Cardiac Death After Heart Attack     2/2/2015
Receptos Provides Update on Progress of Lead Product Candidate RPC1063     6/5/2013
ARCA biopharma Release: Gencaro™ Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and Electrophysiology     1/3/2013
American Diabetes Association Release: Extra Omega-3 Fatty Acids Reduce Severe Arrhythmia-Related Events in Patients With Diabetes and a Previous Heart Attack     11/22/2011
Eisai Company, Ltd. (ESALY.PK) Receives Approval For Additional Indication Of Anti-Arrhythmic Agent Tambocor Tablets For Tachyarrhythmia In Pediatric Patients In Japan     5/14/2010
Eisai Company, Ltd. (ESALY.PK) Submits Application for Additional Indication of Anti-arrhythmic Agent Tambocor(R) Tablets for Tachyarrhythmia in Paediatric Patients in Japan     1/14/2010

//-->